The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I dose escalation (DE) and cohort expansion (CE) study of ERY974, an anti-glypican 3 (GPC3)/CD3 bispecific antibody, in patients with advanced solid tumors.
 
Kenji Hashimoto
Employment - Chugai Pharma
 
Ayesh Perera
Employment - Chugai Pharma Europe
 
Naofumi Sugaya
Employment - Chugai Pharma Europe
 
Yoshitaka Ogita
Employment - Chugai Pharma Europe
 
Mikiko Nakamura
Employment - Chugai Pharma
 
Sheila Rossi
Employment - Chugai Pharma USA
 
Takahiro Ishiguro
Employment - Chugai Pharma
 
Yuji Sano
Employment - Chugai Pharma
 
Sumire Shimada
Employment - Chugai Pharma
 
Werner Frings
Employment - Chugai Pharma
 
Shun-ichiro Komatsu
Employment - Chugai Pharma
 
Akihisa Kaneko
Employment - Chugai Pharma
 
Masamichi Ueda
Employment - Chugai Pharma
 
Junnosuke Matsushima
Employment - Chugai Pharma
 
Shohei Kishishita
Employment - Chugai Pharma
 
Athos Gianella-Borradori
Employment - Chugai Pharma USA